Compounded tirzepatide

Is a compounded tirzepatide seller legit? Four checks

Tirzepatide went on FDA’s shortage list on 15 December 2022 and came off it for good with an agency order on 19 December 2024. Anyone still selling a compounded version is working under narrower rules than the ones that built this market, and four checks show whether a given seller is.

Zepbound vials or KwikPen: $299 per 28 days at 2.5 mg, $399 at 5 mg (a maintenance dose), and $449 at 7.5–15 mg with the Self Pay Journey Program. The $449 rate requires a first fill or refill within 45 days; otherwise regular higher-dose fills cost $499 at 7.5 mg or $699 at 10–15 mg. Eligibility and other terms apply. All comparison amounts use 30.4375 days: each 28-day brand fill × 30.4375 ÷ 28. These are cost equivalents, not checkout charges. Manufacturer terms (checked October 2026).

Why 2025 changed the question²

While the shortage lasted, pharmacies could make copies of the approved injection at scale. FDA first called the shortage over on 2 October 2024. The Outsourcing Facilities Association sued five days later (case 4:24-cv-00953, Northern District of Texas), and the agency took the decision back to reconsider it. The declaratory order of 19 December 2024 settled it again: the shortage was resolved. On 5 March 2025 the court refused to pause that order, and FDA’s 10 March update said the grace period for state-licensed pharmacies had ended. Outsourcing facilities had until 19 March 2025.

What is left is narrower. FDA’s April 2026 update says tirzepatide is on neither the 503B bulks list nor the shortage list, so an outsourcing facility has no route to bulk tirzepatide at all. A state-licensed pharmacy may still compound it for one named patient, but not as an essentially identical copy of the approved injection unless the prescriber documents a significant difference for that patient. A seller that still explains its product by pointing to “the shortage” is giving you a reason that expired in March 2025. The full history, with every docket, is on the legal-status page.

Check 1: a prescriber who can say no

Tirzepatide needs a prescription in every state, whoever makes it. On a genuine program, a clinician licensed where you live reads your intake and has the power to turn you down. That review is the third step of getting it, and it is the step that turns a purchase into treatment. FDA lists “does not require a screening and prescription by a licensed doctor” among its telehealth red flags, along with having no licensed doctor to answer questions once the medicine arrives.¹ If checkout comes before any clinician has seen your answers, stop there.

Check 2: the pharmacy on the label is real, and really made it¹

This is the check tirzepatide makes unusually concrete. FDA reports fraudulent compounded tirzepatide on the US market with false labels: some name a compounding pharmacy that does not exist, and others borrow the name of a licensed pharmacy that, on FDA’s information, never compounded the product. FDA knows of one adverse event tied to a vial labeled as compounded tirzepatide from a pharmacy that did not make it, with redness, swelling, pain and a red lump at the injection site.

So ask the seller which pharmacy fills your prescription, then look that pharmacy up in your state board of pharmacy’s public license search. When the vial arrives, the name and address on its label should match. FDA flags spelling errors on a label, a wrong pharmacy address, and packaging that looks different from what the seller showed you. If a seller says its product comes from an outsourcing facility, that facility should appear on FDA’s registered outsourcing facility list. Given the bulks-list position above, it is also fair to ask how that facility is making tirzepatide today.

Check 3: what is in the box³

Every approved tirzepatide product is an injection. Zepbound alone comes as a single-dose pen, a single-dose vial, a multi-dose vial and a KwikPen, and its label tells prescribers to train each patient on the one they will actually receive. Nothing approved is a tablet, a troche or a drop,⁴ so a seller offering “oral tirzepatide” is offering a form no regulator has reviewed.

Be firmest about anything sold “for research use only” or “not for human consumption.” FDA has warned companies selling tirzepatide under those labels straight to consumers, with dosing instructions, and calls the products of unknown quality.¹ A certificate of analysis is not a substitute for a pharmacy license: it reports what one sample contained and nothing about sterility or the next batch. Payment by wire, crypto or app transfer only, with no card dispute route, belongs to the same pattern. What research-labeled vials are, and FDA’s BeSafeRx advice on online pharmacies generally.

Check 4: FDA’s letters⁵

Warning letters are public, but FDA’s own search tool ignores much of what you type, so a quick search can miss a letter that exists. This site reads the whole corpus and matches letters to the company operating each site, not only to the brand on the homepage, because one operator often runs several storefronts. The result for tirzepatide sellers: 41 of 383 hold at least one letter, each attributed only where the letter names that seller’s own domain. Per-seller detail is on the trust page.

The price test

FDA counts “prices that seem too good to be true” as a red flag, and tirzepatide gives you a firm reference point. The approved product itself, Zepbound in single-dose vials, is listed for self-pay on manufacturer terms with an equivalent calendar-month cost of $325.03 at the starting strength and $488.09 from 7.5 mg up under the qualifying refill program (calendar-month equivalents). The median compounded month on this index is $268.5. A price far below everything else on the index tells you something about the source, and the compounded vs Zepbound comparison shows where the two routes cross as your dose rises.

What this site checks, and what is left to you

Every seller listed here sells through a prescriber. Every one is screened against FDA’s full warning-letter index, and the screen is re-run against a control set before anything publishes. Every price is read on the seller’s own site and dated. Two checks depend on your order and stay with you: which pharmacy your prescription is actually routed to, and whether that pharmacy is licensed in your state. How each seller is verified →